Jun 2, 2026 12:05PM
May 13, 2026 01:36PM
Apr 16, 2026 01:20PM
Feb 24, 2026 12:02PM
Jan 21, 2026 12:02PM
Jan 7, 2026 12:03PM
Jan 7, 2026 12:02PM AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
Dec 15, 2025 12:39PM
Dec 11, 2025 12:29PM
Oct 16, 2025 02:58PM
Oct 16, 2025 02:57PM
Oct 14, 2025 02:36AM
Oct 14, 2025 02:36AM
Oct 10, 2025 12:10PM AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
Jul 30, 2025 01:45AM
Jul 24, 2025 01:57AM
Jul 24, 2025 01:56AM
Jul 4, 2025 02:01AM
Jun 23, 2025 02:03AM
Jun 12, 2025 01:59AM
May 12, 2025 02:14AM AB Science reports its revenues for the year 2024 and provides an update on its activities
Apr 23, 2025 12:59PM
Jan 29, 2025 01:03PM
Dec 17, 2024 01:04PM
Oct 10, 2024 02:27AM
Sep 26, 2024 02:28AM
May 13, 2024 12:08PM
Mar 7, 2024 09:20AM AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
Jan 15, 2024 12:06PM
Sep 29, 2023 01:49PM
Jun 1, 2023 12:01PM
May 17, 2023 02:14PM
May 9, 2023 12:06PM
Apr 28, 2023 12:41PM
Apr 27, 2023 02:41PM AB Science - Summary of the presentation on masitinib in ALS delivered at 2023 AAN Annual Meeting
Apr 18, 2023 12:55PM
Mar 13, 2023 01:09PM
Feb 28, 2023 02:03AM
Dec 29, 2022 12:08PM
Dec 27, 2022 01:04PM
Nov 21, 2022 12:09PM
Apr 29, 2022 12:33PM AB Science reports its revenues for the year 2021 and provides an update on its activities
Jan 19, 2022 12:02PM
Nov 22, 2021 12:20PM
Nov 18, 2021 02:40PM
Oct 18, 2021 12:14PM
Oct 4, 2021 12:10PM
Sep 22, 2021 12:09PM
Jun 28, 2021 01:59PM AB Science announced today that it has signed an agreement with historical shareholders to implement a joint strategy to increase the value of masitinib
Sep 30, 2020 11:57AM

322,203 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All